人类可溶性环氧化物水解酶抑制剂的研究进展

doi:10.6023/cjoc1107132

摘要/Abstract

高血压是现代人的常见疾病. 虽然有很多不同机理的降压药在临床使用, 但是由于个体的差异性, 高血压的治疗越来越倾向于个体化治疗, 因此降压药的使用也不仅仅局限于血压的降低. 人类可溶性环氧化物水解酶抑制剂最大的优势在于其在降压的同时还具有显著的抗炎作用. 详细地阐述了人类可溶性环氧化物水解酶抑制剂从早期的环氧结构类型到第三代脲类结构的发展过程和近期研究进展.

关键词: 可溶性环氧化物水解酶, 花生四烯酸环氧化物, 抑制剂, 1,3-二取代脲, 高血压, 炎症

Hypertension is a common illness nowadays. Although a wide variety of antihypertensive agents are available in the market for the treatment of hypertension, the antihypertensive treatment tends to be individualized, and the treatment should exceed the limitation of lowering blood pressure only. Compared to other antihypertensive agents, the advantage of human soluble epoxide hydrolase inhibitors (HsEHIs) is that they can not only reduce the blood pressure, but also have remarkable anti-inflammatory effects. Herein, the development of human soluble epoxide hydrolase inhibitors is reviewed from early epoxide HsEHIs to the third generation of urea HsEHIs.

Key words: soluble epoxide hydrolase, epoxyeicosatrienoic acid, inhibitors, 1,3-disubstituted urea, hypertension, inflammation

引用此文

黄少胥, 王勇, 龙亚秋. 人类可溶性环氧化物水解酶抑制剂的研究进展[J]. 有机化学, 2012, 32(05): 877-888.

Huang Shaoxu, Wang Yong, Long Yaqiu. Advances in the Research of Human Soluble Epoxide Hydrolase Inhibitors[J]. Chin. J. Org. Chem., 2012, 32(05): 877-888.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

参考文献

[1] Jerina, D. M. Lloydia 1974, 37, 212.

[2] Oliw, E. H. Prog. Lipid Res. 1994, 33, 329.

[3] Morisseau, C. Hammock, B. D. Annu. Rev. Pharmacol. Toxicol.2005, 45, 311.

[4] Hammock, B. D.; Grant, D.; Storms, D. In Comprehensive Toxicology,Eds.: Sipes, I.; McQueen, C.; Gandolfi, A., Pergamon, NewYork, 1997, 283.

[5] Oesch, F. Xenobiotica 1973, 3, 305.

[6] Levin, W.; Michaud, D. P.; Thomas, P. E.; Jerina, D. M. Arch.Biochem. Biophys. 1983, 220, 485.

[7] Pace-Asciak, C. R.; Lee, W. S. J. Biol. Chem. 1989, 264, 9310.

[8] (a) Yu, Z.; Xu, F.; Huse, L. M.; Morisseau, C.; Draper, A. J. Circ.Res. 2000, 87, 992.(b) Davis, B. B.; Thompson, D. A.; Howard, L. L.; Morisseau, C.;Hammock, B. D. Proc. Natl. Acad. Sci U. S. A. 2002, 99, 2222.(c) Imig, J. D.; Zhao, X.; Capdevila, J. H.; Morisseau, C.; Hammock,B. D. Hypertension 2002, 39, 690.(d) Zhao, X.; Yamamoto, T.; Newman, J. W.; Kim, I. H.; Watanabe,T. J. Am. Soc. Nephrol. 2004, 15, 1244.

[9] Arand, M.; Grant, D. F.; Beetham, J. K.; Friedberg, T.; Oesch, F.;Hammock, B. D. FEBS Lett. 1994, 338, 251.

[10] Ollis, D. L.; Cheah, E.; Cygler, M.; Dijkstra, B.; Frolow, F. Curr.Protein Pept. Sci. 2000, 1, 209.

[11] Moghaddam, M. F.; Grant, D. F.; Cheek, J. M.; Greene, J. F.; Williamson,K. C.; Hammock, B. D. Nat. Med. 1997, 3, 562.

[12] Morisseau, C.; Goodrow, M. H.; Dowdy, D.; Zheng, J.; Greene, J.F.; Sanborn, J. R.; Hammock, B. D. Proc. Natl. Acad. Sci. U. S. A.1999, 96, 8849.

[13] Spector, A. A.; Fang, X.; Snyder, G. D.; Weintraub, N. L. Prog.Lipid Res. 2004, 43, 55.

[14] (a) Imig, J. D.; Zhao, X.; Zaharis, C. Z.; Olearczyk, J. J.; Pollock,D. M.; Newman, J. W.; Kim, I.-H.; Watanabe, T.; Hammock, B. D.Hypertension 2005, 46, 975.(b) Ai, D.; Fu, Y.; Guo, D.; Tanaka, H.; Wang, N.; Tang, C.;Hammock, B. D.; Shyy, J. Y.-J.; Zhu, Y. Proc. Natl. Acad. Sci. U.S. A. 2007, 104, 9018.

[15] Sinal, C. J.; Miyata, M.; Tohkin, M.; Nagata, K.; Bend, J. R.; Gonzalez,F. J. J. Biol. Chem. 2000, 275, 40504.

[16] Kim, I.-H.; Nishi, K.; Tsai, H.-J.; Bradford, T.; Koda, Y.; Watanabe,T.; Morisseau, C.; Blanchfield, J.; Tothb, I.; Hammock, B. D.Bioorg. Med. Chem. 2007, 15, 312.

[17] The ALLHAT Officers and Coordinators for the ALLHAT CollaborativeResearch Group J. Am. Med. Assoc. 2002, 288, 2981.

[18] Schmelzer, K. R.; Inceoglu, B.; Kubala, L.; Kim, I. H.; Jinks, S. L.;Eiserich, J. P.; Hammock, B. D. Proc. Natl. Acad. Sci. U. S. A.2006, 103, 13646.

[19] Mullin, C. A.; Hammock, B. D. 1982, 216, 423.

[20] Dietze, E. C.; Kuwano, E.; Casas, J.; Hammock, B. D. Biochem.Pharmacol. 1991, 42, 1163.

[21] Morisseau, C.; Du, G.; Newman, J. W.; Hammock, B. D. Arch.Biochem. Biophys. 1998, 356, 214.

[22] Draper, A. J.; Hammock, B. D. Toxicol. Sci. 1999, 52, 26.

[23] Gaetke, L. M.; McClain, C. J.; Talwalkar, R. T.; Shedlofsky, S. I.Am. J. Physiol. Endocrin. Metab. 1997, 272, E952.

[24] Dietze, E. C.; Kuwano, E.; Hammock, B. D. Anal. Biochem. 1994,216, 176.

[25] Jones, P. D.; Wolf, N. M.; Morisseau, C.; Whetstone, P.; Hock, B.;Hammock, B. D. Anal. Biochem. 2005, 343, 66.

[26] Argiriadi, M. A.; Morisseau, C.; Hammock, B. D.; Christianson, D.W. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 10637. [27] Morisseaua, C.; Goodrow, M. H.; Newman, J. W.; Wheelock, C.E.; Dowdy, D. L.; Hammock, B. D. Biochem. Pharmacol. 2002, 63,1599.

[28] Kim, I.-H.; Morisseau, C.; Watanabe, T.; Hammock, B. D. J. Med.Chem. 2004, 47, 2110.

[29] Kim, I.-H.; Heirtzler, F. R.; Morisseau, C.; Nishi, K.; Tsai, H.-J.;Hammock, B. D. J. Med. Chem. 2005, 48, 3621.

[30] (a) Argiriadi, M. A.; Morisseau, C.; Goodrow, M. H.; Dowdy, D.L.; Hammock, B. D.; Christianson, D. W. J. Biol. Chem. 2000, 275,15265.(b) Gomez, G. A.; Morisseau, C.; Hammock, B. D.; Christianson,D. W. Biochemistry 2004, 43, 4716.

[31] Morisseau, C.; Newman, J. W.; Tsai, H.-J.; Baecker P. A.; Hammock,B. D. Bioorg. Med. Chem. Lett. 2006, 16, 5439.

[32] Jones, P. D.; Tsai, H.-J.; Do, Z. N.; Morisseau, C.; Hammock, B. D.Bioorg. Med. Chem. Lett. 2006, 16, 5212.

[33] Li, H.-Y.; Jin, Y.; Morisseau, C.; Bruce, D.; Hammock, B. D.;Long, Y.-Q. Bioorg. Med. Chem. 2006, 14, 6586.

[34] Huang, S.-X.; Li, H.-Y.; Liu, J.-Y.; Morisseau, C.; Hammock, B.D.; Long, Y.-Q. J. Med. Chem. 2010, 53, 8376.

[35] Kasagami, T.; Kim, I.-H.; Tsai, H.-J.; Nishi, K.; Hammock, B. D.;Morisseau, C. Bioorg. Med. Chem. Lett. 2009, 19, 1784.

[36] Anandan, S.-K.; Webb, H. K.; Do, Z. N.; Gless, R. D. Bioorg. Med.Chem. Lett. 2009, 19, 4259.

[37] Rose, T. E.; Morisseau, C.; Liu, J.-Y.; Inceoglu, B.; Jones, P. D.;Sanborn, J. R.; Hammock, B. D. J. Med. Chem. 2010, 53, 7067.

[38] Eldrup, A. B.; Soleymanzadeh, F.; Farrow, N. A.; Kukulka, A.; DeLombaert, S. Bioorg. Med. Chem. Lett. 2010, 20, 571.

[39] Kim, I.-H.; Park, Y.-K.; Hammock, B. D.; Nishi, K. J. Med. Chem.2011, 54, 1752.

[40] Xie, Y.; Liu, Y.; Gong, G.; Smith, D. H.; Yan, F.; Rinderspacher,A.; Feng, Y.; Zhu, Z.; Li X.; Deng, S.-X.; Branden, L.; Vidovi?, D.;Chung, C.; Sch黵er, S.; Morisseau, C.; Hammock, B. D.; Landry,D. W. Bioorg. Med. Chem. Lett. 2009, 19, 2354.

[41] Taylor, S. J.; Soleymanzadeh, F.; Eldrup, A. B.; Farrow, N. A.;Muegge, I.; Kukulka, A.; Kabcenell, A. K.; De Lombaert, S. Bioorg.Med. Chem. Lett. 2009, 19, 5864.

[42] Eldrup, A. B.; Soleymanzadeh, F.; Taylor, S. J.; Muegge, I.;Farrow, N. A.; Joseph, D.; McKellop, K.; Man, C. C.; Kukulka, A.;De Lombaert, S. J. Med. Chem. 2009, 52, 5880.

[43] (a) Shen, H. C.; Ding, F.-X.; Wang, S.; Deng, Q.; Zhang, X.; Chen,Y.; Zhou, G.; Xu, S.; Chen, H.-S.; Tong, X.; Tong, V.; Mitra, K.;Kumar, S.; Tsai, C.; Stevenson, A. S.; Pai, L.-Y.; Alonso-Galicia,M.; Chen, X.; Soisson, S. M.; Roy, S.; Zhang, B.; Tata, J. R.; Berger,J. P.; Colletti, S. L. J. Med. Chem. 2009, 52, 5009.(b) Shen, H. C.; Ding, F.-X.; Wang, S.; Xu, S.; Chen, H.-S.; Tong,X.; Tong, V.; Mitra, K.; Kumar, S.; Zhang, X.; Chen, Y.; Zhou, G.;Pai, L.-Y.; Alonso-Galicia, M.; Chen, X.; Zhang, B.; Tata, J. R.;Berger, J. P.; Colletti, S. L. Bioorg. Med. Chem. Lett. 2009, 19,3398.(c) Shen, H. C.; Ding, F.-X.; Deng, Q.; Xu, S.; Tong, X.; Zhang,X.; Chen, Y.; Zhou, G.; Pai, L.-Y.; Alonso-Galicia, M.; Roy, S.;Zhang, B.; Tata, J. R.; Berger, J. P.; Colletti, S. L. Bioorg. Med.Chem. Lett. 2009, 19, 5716.(d) Shen, H. C.; Ding, F.-X.; Deng, Q.; Xu, S.; Chen, H.-S.; Tong,X.; Tong, V.; Zhang, X.; Chen, Y.; Zhou, G.; Pai, L.-Y.;Alonso-Galicia, M.; Zhang, B.; Roy, S.; Tata, J. R.; Berger, J. P.;Colletti, S. L. Bioor. Med. Chem. Lett. 2009, 19, 5314.

[44] Xing, L.; McDonald, J. J.; Kolodziej, S. A.; Kurumbail, R. G.; Williams,J. M.; Warren, C. J.; O'Neal, J. M.; Skepner, J. E.; Roberds,S. L. J. Med. Chem. 2011, 54, 1211.

[45] Tanaka, D.; Tsuda, Y.; Shiyama, T.; Nishimura, T.; Chiyo, N.; Tominaga,Y.; Sawada, N.; Mimoto, T.; Kusunose, N. J. Med. Chem.2011, 54, 851.